STING1 and neoplasm: Research has indicated that enhanced glycolytic efficiency in tissue samples obtained from NSCLC patients increased the production of glycolytic ATP in tumor-infiltrating DCs, thereby activating STING signal transduction to promote DC-mediated anti-tumor immune response.